These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 34076905
1. ELISPOT assay of interferon-γ secretion for evaluating human cytomegalovirus reactivation risk in allo-HSCT recipients. Liang H, Xia J, Zhang R, Yang B, Wu J, Gui G, Huang Y, Chen X, Yang R, Wang H, Gong S, Fan J. J Med Virol; 2021 Nov; 93(11):6301-6308. PubMed ID: 34076905 [Abstract] [Full Text] [Related]
2. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays. Liu A, Ma Y, Wu W, Chen X, Huang Y, Hu J, Liang H, Wang H, Yang R, Fan J. J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932 [Abstract] [Full Text] [Related]
3. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients. Calarota SA, Chiesa A, Scaramuzzi L, Adzasehoun KM, Comolli G, Mangione F, Esposito P, Baldanti F. J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915 [Abstract] [Full Text] [Related]
4. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs. Nemeckova S, Krystofova J, Babiarova K, Hainz P, Musil J, Sroller V, Maly M, Stastna-Markova M. Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389 [Abstract] [Full Text] [Related]
5. The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF. J Infect Dis; 2019 Feb 23; 219(6):898-907. PubMed ID: 30295846 [Abstract] [Full Text] [Related]
6. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients. Tormo N, Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, López-Aldeguer N, Hernández-Boluda JC, Remigia MJ, Garcia-Noblejas A, Gimeno C, Navarro D. Bone Marrow Transplant; 2010 Mar 23; 45(3):543-9. PubMed ID: 19617905 [Abstract] [Full Text] [Related]
10. Secretion of IFN-γ by specific T cells in HCMV infection. Liang H, Gong S, Gui G, Wang H, Jiang L, Li X, Fan J. Heliyon; 2024 Mar 30; 10(6):e28177. PubMed ID: 38533049 [Abstract] [Full Text] [Related]
15. Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients. Abate D, Saldan A, Mengoli C, Fiscon M, Silvestre C, Fallico L, Peracchi M, Furian L, Cusinato R, Bonfante L, Rossi B, Marchini F, Sgarabotto D, Rigotti P, Palù G. J Clin Microbiol; 2013 Aug 30; 51(8):2501-7. PubMed ID: 23678073 [Abstract] [Full Text] [Related]
16. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital. Fleming T, Dunne J, Crowley B. J Med Virol; 2010 Mar 30; 82(3):433-40. PubMed ID: 20087937 [Abstract] [Full Text] [Related]